MAYS vs NBIX · rev $22.5M vs P/E 45, rev $1.77B
J W Mays Inc (MAYS) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
J W Mays Inc (MAYS) is a real estate services company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported MAYS revenue for 2025-07-31 was $22.5M. Net income was -$136.2K. MAYS currently screens at market cap $75.9M.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
MAYS currently screens at market cap $75.9M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the MAYS and NBIX stock pages for the full models.
Not investment advice.